Dapagliflozin: A Diabetes Medicine That Also Protects the Heart and Kidneys
Introduction
Dapagliflozin is an oral prescription medicine used to treat type 2 diabetes. It belongs to a group of medicines called sodium-glucose co-transporter 2 (SGLT2) inhibitors. In addition to lowering blood sugar, it helps protect the heart and kidneys in many patients.
Uses of Dapagliflozin
Dapagliflozin is used to:
- Improve blood sugar control in adults with type 2 diabetes
- Reduce the risk of hospitalization due to heart failure
- Slow the progression of chronic kidney disease in eligible patients
- Lower the risk of cardiovascular death in certain people with heart failure
How Does It Work?
Dapagliflozin blocks the SGLT2 protein in the kidneys. This causes excess glucose to be removed from the body through urine, helping lower blood sugar levels. It also provides benefits for heart and kidney health.
Common Adverse Effects
Common side effects include:
- Frequent urination
- Urinary tract infections
- Genital fungal infections
- Increased thirst
- Dizziness
Rare but serious side effects include diabetic ketoacidosis, severe dehydration, and kidney problems.
Drug Interactions
Dapagliflozin may interact with:
- Insulin and sulfonylureas, increasing the risk of low blood sugar
- Diuretics, increasing the risk of dehydration
- Other blood pressure-lowering medicines, which may increase dizziness
Precautions
This medicine is not recommended for people with type 1 diabetes. Patients should drink enough water and inform their doctor if they develop severe illness, vomiting, or symptoms of ketoacidosis.
Conclusion
Dapagliflozin is more than a diabetes medicine. It also offers important heart and kidney benefits, making it a valuable treatment option when used under medical supervision.
MBH/PS